INSURASALES

Medicare Advantage Payments Set to Rise 5.06% for 2026

The 2026 Rate Announcement reveals a 5.06% increase in Medicare Advantage payments, protecting beneficiaries and addressing fraud.

CMS Increases Medicare Advantage Payments by Over $25 Billion

CMS has raised payments to Medicare Advantage plans by 5%, raising concerns over care quality for seniors. Critics decry potential overcharging and fraud.

Study Reveals Huge Revenue Discrepancies in Medicare Plans

A study finds Medicare Advantage plans receive $33 billion more than Traditional Medicare, raising concerns about coding practices and insurer profits.

Impact of Tariffs on Prescription Drug Prices Discussed

Dr. Elliott discusses the impact of tariffs on prescription drug prices and answers listener questions on healthcare.

Medicare Advantage Plans Earn $33 Billion More in 2021

An analysis shows Medicare Advantage plans earned $33 billion more than Traditional Medicare in 2021 through coding differences. UnitedHealth Group received the largest share.

UnitedHealth Dominates Medicare Advantage Payments: Study

Explore how UnitedHealth Group leads in Medicare Advantage payments through diagnosing more health conditions, raising concerns in the health insurance sector.

Can Advanced Practice Providers Alleviate Physician Shortages?

Exploring the role of Advanced Practice Providers in alleviating physician shortages and the implications of AI in healthcare.

Impact of the Inflation Reduction Act on Prescription Costs

Explore the influence of the Inflation Reduction Act on Medicare's prescription cost caps, reducing financial toxicity for patients.

Senate Confirms Oz to Lead Medicare and Medicaid Amid Fiery Budget Debate

The Senate votes to confirm Mehmet Oz for Medicare and Medicaid, amidst concerns over potential budget cuts and their impact on healthcare access.

DOJ Pushes On Against UnitedHealth Despite Special Master's Report

The DOJ is pressing forward with a lawsuit against UnitedHealth Group, challenging a special master’s report that found insufficient evidence against the health giant concerning Medicare Advantage payments.